In this free webinar, learn about leveraging patent intelligence and network analysis to quantify technology influence in CRISPR. Attendees will learn about quantifying the influence of organisations involved in CRISPR. The featured speaker will introduce network analysis and speak about leveraging patents as an indicator of relationships between businesses.
TORONTO, June 7, 2022 /PRNewswire-PRWeb/ -- CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) as a technology is akin to a pair of gene scissors that can target and cut a DNA sequence. This revolutionary gene editing method allows scientists to rewrite the genetic code in almost any organism, while being cheaper, simpler and more precise than any of its gene-editing predecessors. Unsurprisingly, interest in this field is increasing at an exponential rate. New innovations in agriculture, treatments of debilitating illnesses, and genetic prevention of inherited illness are all being explored in detail.
While CRISPR as a technology is both novel and exciting, assessing which companies, inventors and new entrants to keep your eye on can be a challenging task. Typically, concepts such as influence can be difficult to pin down and are at the mercy of subjectivity.
In this webinar, the featured speaker explores ways to quantify such ideas and to pin down exactly who the "influential" entities are by the relationships they foster. The vehicle used to explore this idea is patent co-ownership. Patents are often a key component in the protection and commercialisation strategies of businesses, and co-ownership of patents can point to relationships between organisations.
As CRISPR is a relatively new technology, innovations tend to require lots of research and are often capital intensive, as is typically the case with developments in the life science industry, so these collaborative relationships become more common. Network analysis allows the leveraging of graph theory to make sense of a high volume of connections. These connections can be quantified and assessed to compare their relative quality, and therefore the level of influence an entity might have within the context of the industry network.
Join this webinar to learn more about leveraging patent intelligence and network analysis to quantify technology influence in CRISPR.
Join Frazer Kearl, Research & Data Analyst, PatSnap, for the live webinar on Thursday, June 23, 2022, at 12pm EDT (9am PDT).
For more information, or to register for this event, visit Leveraging Patent Intelligence and Network Analysis to Quantify Technology Influence in CRISPR.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]
SOURCE Xtalks
Share this article